Web Stats Provided By Google Analytics

Wednesday, January 22, 2014

ViiV Healthcare's new HIV medicine Tivicay(TM) (dolutegravir) is approved in Europea

... who participated in it, and we aim to move forward together with them based on an absolute commitment to the HIV/AIDS global response," said Dr Dominique Limet, Chief Executive Officer, ViiV Healthcare. Today's approval of Tivicay is the European ...

http://ift.tt/1jn3AQ2

No comments:

Post a Comment